selected publications
-
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Diabetes care.
2021
Academic Article
GET IT
Times cited: 37 -
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
The New England journal of medicine.
2020
Academic Article
GET IT
Times cited: 92 -
Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials.
Diabetes, obesity & metabolism.
2019
Academic Article
GET IT
Times cited: 8 -
GREATER COMBINED REDUCTIONS IN HbA1C ≥1.0% AND WEIGHT ≥5.0% WITH SEMAGLUTIDE VERSUS COMPARATORS IN TYPE 2 DIABETES.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2019
Academic Article
GET IT
Times cited: 10 -
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.
Diabetes, obesity & metabolism.
2018
Academic Article
GET IT
Times cited: 65 -
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.
Clinical and translational science.
2008
Academic Article
GET IT
Times cited: 244 -
Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus.
The American journal of cardiology.
2006
Academic Article
GET IT
Times cited: 55 -
Acute insulin secretion as a predictor of weight gain in healthy humans.
Obesity (Silver Spring, Md.).
2006
Academic Article
GET IT
Times cited: 12 -
Management of thyroid incidentalomas.
The Surgical clinics of North America.
2004
Review
GET IT
Times cited: 43